Christopher M. Starr, Chief Executive Officer at Raptor Pharmaceutical Corp (RPTP), sold 25,000 shares at $12.74 ($308K) on 2013-11-15, disclosed to the SEC on 2013-11-19.
Scheduled sale ($308k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.84 | 12,000 | $142K | 46.2% |
| 2 | $12.74 | 13,000 | $166K | 53.8% |
| Total | $12.31 avg | 25,000 | $308K | 100% |
| Filing → |
| RPTP | SELL | 2015-03-18 | $352K | — | Filing → |
| RPTP | SELL | 2015-02-25 | $286K | — | Filing → |
| RPTP | SELL | 2015-02-19 | $281K | — | Filing → |